Research is exploring the role of immune checkpoint inhibitors in cancer therapy, with studies investigating various approaches to enhance the immune system's attack on tumors. Some findings suggest that certain molecules, including those derived from gut bacteria, can help reverse immune suppressive mechanisms and improve immunotherapy responses. The field of cancer immunotherapy is advancing with new developments, including potential small molecule drugs and innovative delivery methods, such as inhalable nanotherapy.